As CEO of Validose, I lead the development, launch, and scaling of a pioneering controlled dosing technology platform that integrates biometrically enabled, customizable dose devices with a secured gateway data ecosystem to provide a comprehensive use environment and ensure safe, controlled medication use, addressing today’s critical drug adherence challenges.

Consultancy focused on holistic solutions for emerging Life Sciences ventures, value creation, rapid scalability, and integration across multiple application verticals to maximize market disruption. Project work includes: ► U.S Health Technology Platform (SaaS) - Grew customer acquisition by 35% for health practice management software co. through a streamlined sales approach and re-focusing marketing on patient access & reimbursement benefits. ► Global Pharmaceutical Company (Life Sciences) - Delivered a +10% sales increase to the international division through a revamped commercial operations approach, including a new sales and shared services model, streamlining region and providing differentiated offerings to secondary markets.► Global Durable Medical Equipment (Medical Device) - Exceeded tranche two sales targets for launching a medical device / clinical service platform by organizing a new B2B market entry approach and new clinical engagement marketing approaches. ► US Health Services Company (HealthTech & Service): Led founder team initiative to restart the round 1 development for a concierge health start-up by designing a new digital experience (DX) strategy and sales model targeting multi-category consumer offerings covering pharmaceuticals, vitamins, and beauty segments.

Managed combination of GSK Digestive & Pfizer Nutritional businesses to create the leading Global Consumer Nutrition business totaling $2.4 Billion in annual revenue, spanning 75+ countries and 880 colleagues: responsible for marketing, digital experience, innovation & supply functions, strategic marketing/business planning, and full P&L responsibility. ► Delivered Year 1 results of 119% of the budget through the assembly of a new global wellness operating model, onboarding of new leadership, training of marketing and operations teams, and promotion of a new cultural model prioritizing streamlined work & transparency; completed within year one.► Exceeded +75% growth in innovation output in 12 months through the setup of an innovation model, including building marketing/R&D/Regulatory approach, product development, and pipeline governance.► Produced a +21% increase in e-commerce marketing & sales contribution within the Nutritional category through an updated CRM approach with greater emphasis on conversion, a new innovation process that cut the 24-month launch time down to 3, and an expansion of disruptive channels with new e-consult and subscription model offerings.► Designed & implemented the first global wellness category strategy, managing the cross-enterprise process to evaluate the $50 billion Global Wellness category and design a pathway to sustained market leadership across vitamin, beauty & digestive segments. Work identified an improved integrated marketing/innovation approach and enterprise-wide capability enhancement plan.

Selected to manage the integration of GSK and Pfizer Consumer EMEA regions – creating the largest EMEA consumer health business; spanned 50 countries, included 700+ colleagues, and $3.8 Billion in annual revenue. ► Successfully integrated a cross-functional team of 42 professionals from two companies and 6 functions through tight-timeline and complex management, regulatory & labor approval; the team encompassed marketing, sales, finance, strategy, innovation, and supply functions. ► Oversaw assembly of the regional integration plan, including market clustering, 3-year forecast, synergies identification, initial M&A priorities, and year-one leadership team recommendation. ► Recognized by Global Leadership for designing a new regional business utilizing Hub/Spoke alignment of marketing, sales, innovation & support functions; adopted an organization's standard model approach.

Recruited to lead interim regional marketing organization for EMEA region, spanning 42 countries and five direct reports: responsible for full P&L and all marketing/digital experience elements, including media, SEO, and social media marketing. ► Transformed team to move with agility, upscale digital & 1st party data capabilities, enhance brand authenticity and cultural relevance, and deliver consumer-inspired digital strategies leveraging consumer roadmap journeys. ► Improved message breakthrough by +20% through prioritizing focus on Multi-Vitamins, Gut Health, Energy & Hydration segments with new claims & insight driven RTB within the new CRM model.

Led transformation of EMEA region (42-country, 580 employees, $600M annual sales) sales and marketing, supply & innovation functions to return the area to profitability; responsible for marketing, sales, innovation, new business development, and strategic partnerships with full P&L responsibilities. ► Delivered a 1,000-basis point turnaround within 18 months by redesigning marketing management, innovation, and sales management to a cluster market system with improved accountability and new standardized performance metrics (pipeline, conversion, net profit, customer engagement health, ongoing core business). ► Exceeded +15% improvement in product pipeline through simplified marketing & innovation approach - reducing markets of focus, improving investment in growth areas, and eliminating long-tail pipeline. ► Achieved +45% sales increase through re-stage of European IMEDEEN beauty supplement brand that introduced improved point of differentiation, simplified product line and strategic pricing. ► Mktg: Using a new programmatic mobile targeting approach, we improved advertising ROI by 35%, driving improved brand health over two years. ► Returned French & Middle East markets to profitability through restructuring of sales organizations. ► Led M&A for Be-Total brand, completing acquisition within 100 days, delivering 100% of Y1 budget.

Selected by Global President to lead US Rx-to-OTC switch of prescription Nexium, managing all elements of US Switch execution including P&L, marketing, digital experience, promotion, media, and supply to elevate the brand to #1 share.► Exceeded $350MM in year one sales and grew category by 19%, launching the largest Rx-to-OTC switch in the new FDA regulation era and leading a cross-functional team of 42 marketing, sales, and supply colleagues. ► Achieved 50% ACV within 72 hours of launch through a new innovative speed-to-market distribution approach, enabling Pfizer's first-ever week-one advertising blitz.► Delivered #1 share within 14 weeks through the launch of a targeted consumer adoption approach using a behavior-based consumer experience journey with an integrated online advertising / retail path-to-purchase.► Accomplished 23% brand awareness within four months of launch through a new medical marketing platform targeting unique physician support for the PPI product segment.

Promoted to overhaul the most extensive brand portfolio at Pfizer and deliver stable, profitable category leadership.► Elevated Children’s and Advil PM brands to the # 1 share position by restructuring the $720M portfolio with 58 cross-functional colleagues through simplifying message against the leading point of differentiation, standardizing marketing and product management execution across functions, and improving P&L ROI. ► Championed 15% COGS reduction via rebuilding portfolio shared services to adopt a ‘single chassis’ system.► Led division for highest ROI promotion execution through execution of portfolio price architecture and trade analytics program; decreased portfolio from 23 to 7 price points.

Lead all elements of the Pfizer brand, elevating business to the #1 share position in the commoditized pain market.► Delivered 2x growth vs. 3Y CAGR through restructuring $450M brand & cross-functional team of 32 to focus on disruptive benefit message coordinated with revamped promotion model to amplify benefit message.► Utilized a new layered messaging campaign to dimensionalize core-benefit message elements across functional & emotional connection points with the core target. ► Improved message awareness by 70% through a new doctor engagement platform. ► Achieved +17% sales growth through a new ‘footprint’ approach, utilizing a staggered approach promotion & media model focused on maximizing user acquisition.